Polygenic risk modeling of tumor stage and survival in bladder cancer
Abstract Introduction Bladder cancer assessment with non-invasive gene expression signatures facilitates the detection of patients at risk and surveillance of their status, bypassing the discomforts given by cystoscopy. To achieve accurate cancer estimation, analysis pipelines for gene expression da...
Main Authors: | Mauro Nascimben, Lia Rimondini, Davide Corà, Manolo Venturin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | BioData Mining |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13040-022-00306-w |
Similar Items
-
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
by: Dimitrios Vlachakis, et al.
Published: (2021-06-01) -
Polygene Risk Scores
by: James Woodward, et al.
Published: (2023-07-01) -
The False Dawn of Polygenic Risk Scores for Human Disease Prediction
by: Anthony F. Herzig, et al.
Published: (2022-07-01) -
Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
by: Hannah Stocker, et al.
Published: (2023-07-01) -
Constructing an atlas of associations between polygenic scores from across the human phenome and circulating metabolic biomarkers
by: Si Fang, et al.
Published: (2022-10-01)